Inspire Medical (TASE:PMCN) Systems has established itself as a key player in the sleep apnea treatment market ... The medical device industry is subject to regulatory scrutiny, and any delays ...

Leerink Partners analysts said the results were largely in line with outcomes seen in a trial of Inspire Medical Systems’ rival device. The analysts see ways that Livanova could differentiate its ...

A newer option is a surgically implanted device called Inspire (inspiresleep.com). Approved in 2014 ... treatment Zepbound – ...

The first choice of treatment for sleep apnea is positive airway pressure (PAP) therapy, which requires sleeping with a small mask over your nose or over your nose and mouth. Usually, this involves ...

Inspire Medical (TASE:PMCN) Systems has established itself as a key player in the sleep apnea treatment market. The company's focus on developing and ... Despite INSP's strong performance and positive ...

Inspire Medical Systems (NYSE:INSP) announced today that it entered into an accelerated share repurchase program worth $75 ...

Oxygen therapy for obstructive sleep apnea (OSA) treatment is not a first-line treatment. It might help, though oxygen typically may not be considered unless continuous positive airway pressure (CPAP) ...